TY  - JOUR
AU  - Gonçalves Rossi, Livia Maria 
AU  - Rahal, Paula 
PY  - 2015
TI  - Detection of Hepatitis C Virus Resistant Mutants in the era of Direct Acting Antivirals
JF  - American Journal of Infectious Diseases
VL  - 10
IS  - 4
DO  - 10.3844/ajidsp.2014.179.183
UR  - https://thescipub.com/abstract/ajidsp.2014.179.183
AB  - Hepatitis C Virus (HCV) infects millions of people and represents an important public health problem in different regions of the world. Drug resistance is a major challenge for HCV-infection related control. Importantly, the arrival of a plethora of novel, more powerful drugs has revolutionized the field of HCV treatment. Here, we discuss the relevance of identification of HCV resistant mutants from a clinical standpoint. The advantage and limitations of molecular testing in clinical setting is presented.